DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160706

Pattern of vitamin D status in prediabetic individuals: a case control study at tertiary hospital in South India

Srinath K. M., Shashidhara K. C., Rajeev Reddy G., Madhu Basavegowda, Kishaloy Debnath, Mahesh M.G.

Abstract


Background: Role of vitamin D in the regulation of calcium metabolism is well established. Vitamin D deficiency has been linked to impaired glucose tolerance and type 2 DM in humans. There is a limited available data on the relationship of vitamin D insufficiency/deficiency with glucose homeostasis among prediabetic individuals in South Indian population. Hence we examined serum 25(OH) D3 concentration among prediabetics. The objective of this study is to evaluate prevalence of vitamin D deficiency in prediabetics and to study any correlation between vitamin D and BMI, FBS and PPBS among prediabetics.  

Methods: A case control study was carried out among 40 prediabetics & controls, after obtaining consent from subjects and clearance from institutional ethics committee. Serum vitamin D levels were measured by radioimmunoassay in both groups. Statistical analysis was done using “t” test & Pearson correlation co-efficient (r).

Results: Vitamin D levels less than 20 ng/ml were found in 72.5% of cases and 35% of controls. 5% of the cases and 12.5% of the controls had vitamin D above 30 ng/ml and this difference was statistically significant. Mean vitamin D levels in cases and controls was 17.09±5.89 ng/ml and 23.67±11.02 ng/ml respectively (P<0.05). A significant inverse correlation was observed between vitamin D levels & body mass index (r=-0.274; p=0.014); random blood sugar (r=-0.35; p=0.001); fasting blood sugar (r=-0.328; p=0.003); post prandial blood sugar (r=-0.276; p=0.013).

Conclusions: High prevalence of hypovitaminosis D exists among prediabetics and there is significant inverse correlation between BMI, FBS, PPBS and vitamin D levels. Hence, a prospective study covering large pre-diabetic individuals is essential to confirm the findings.

 


Keywords


Vitamin D, Vitamin D deficiency, Prediabetes, Type 2 DM, Prevalence

Full Text:

PDF

References


Executive summary. Standards of Medical Care in Diabetes-2010. Diabet Care. 2009;33(1):S4-10.

Weyer C, Bogardus C, Mott D, Pratley R. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Investig. 1999;104(6):787-94.

Gerstein H, Santaguida P, Raina P, Morrison K, Balion C, Hunt D et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabet Res Clin Pract. 2007;78(3):305-12.

Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance. Diabet Care. 2007;30:753-9.

Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252-61.

Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820-5.

Hypponen E, Boucher B, Berry D, Power C. 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2007;57(2):298-305.

Boucher B, Mannan N, Noonan K, Hales C, Evans S. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia. 1995;38(10):1239-45.

Scragg R, Sowers M, Bell C. Serum 25-Hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabet Care. 2004;27(12):2813-8.

Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017-29.

Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? BJN. 2003;89(05):552.

Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson C. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012;55(6):1668-78.

Holicl MF, Chen TC. Vitamin-D deficiency a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-6S.

Savastano S, Somma CD, Colao A. Vitamin-D & prediabetes: a promising ménage in the Indian scenario. Indian J Med Res. 2013;138(6):829-30.

Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S.

Holick MF. High prevalence of vitamin D inadequacy and implications for health. In Mayo Clinic Proceedings. 2006;31(81):353-73.

Holick MF. McCollum award lecture, vitamin d—new horizons for the 21st century. Am J Clin Nutr. 1994;60:619-30.

Engelsen O, Brustad M, Aksnes L, Lund E. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochemistry and photobiology. 2005;81(6):1287-90.

Need AG, O’Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol. 2005;62:738-41.

Ford ES, Ajani UA, McGuire LC, Liu S. Concentration of serum vitamin D and the metabolic syndrome among U.S. adults. Diabet Care 2005;28:1228-30.

Fourouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C et al. Circulating 25-hydroxyvitamin-D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC) Norflok cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173-82.

Braun TR, Been LF, Blackett PR, Sanghera DK. Vitamin D deficiency and cardio-metabolic risk in a north Indian community with highly prevalent type 2 diabetes. J Diabet Metabol. 2012;3:10.4172/2155-6156.1000213.

Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, et al Serum Vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res. 2013;138:853-60.

Shankar A, Sabanayagam C, Kalidindi S. Serum 25-hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabet care. 2011;34(5):1114-9.

Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabet Care. 2004;27(12):2813-8.

Sugden J, Davies J, Witham M, Morris A, Struthers A. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320-5.

Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev. 2013;14:393-404.

Cimbek A, Gursoy G, Kirnap N, Acar Y, Erol B, Ozasik I et al. Relation of Serum 25 Hydroxy Vitamin D3 levels with insulin resistance in type 2 diabetic patients and normal subjects. Med Sci. 2012;1(4):305-14.

Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index. A systematic review and meta-analysis. Obes Rev. 2013;14(5):393-404.

Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57:2619-25.

Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin-D and risk of type 2 diabetes :a prospective cohort study and metaanalysis. Clin Chem. 2013;59(2):381-91.

Zella JB, DeLuca H F. Vitamin D and autoimmune diabetes. J Cell Biochem. 2003;88(2):216-22.

Strugnell S, DeLuca H. The vitamin D receptor-structure and transcriptional activation. Experimental Biol Med. 1997;215(3):223-8.

Nemere I, Schwartz Z, Pedrozo H, Sylvia V, Dean D, Boyan B. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res. 1998;13(9):1353-9.

Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys. 2000;374(2):334-8.

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Fried J et al. Vitamin D3 down regulates monocyte TLR expression and triggers hypo responsiveness to pathogen-associated molecular patterns. European J Immunol. 2006;36(2):361-70.

Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-dihydroxyvitamin D3 works as anti-inflammatory. Diabet Res Clin Pract. 2007;77(1):47-57.

Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82-92.

Inomata S, Kadowaki S, Yamatani T. Effect of 1α(OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone and Mineral. 1986;1(3):187-92.

Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man, Diabetologia. 1986;29(3):142-5.

Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Post Graduate Med J. 1994;70(824):440-3.

McCarty MF. Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypoth. 2009;72(6):647-51.